FEDERICO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 1.037
EU - Europa 696
AS - Asia 230
AF - Africa 17
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.988
Nazione #
US - Stati Uniti d'America 1.036
FI - Finlandia 187
IT - Italia 156
CN - Cina 139
UA - Ucraina 110
DE - Germania 96
SG - Singapore 59
IE - Irlanda 37
SE - Svezia 32
GB - Regno Unito 21
CI - Costa d'Avorio 16
FR - Francia 16
RU - Federazione Russa 15
BE - Belgio 13
IN - India 9
KR - Corea 8
RO - Romania 8
HK - Hong Kong 5
IR - Iran 4
EU - Europa 3
CO - Colombia 2
GR - Grecia 2
KZ - Kazakistan 2
NL - Olanda 2
PE - Perù 2
AR - Argentina 1
CA - Canada 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
LB - Libano 1
MY - Malesia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.988
Città #
Ann Arbor 134
Chandler 132
Ashburn 97
Woodbridge 90
Fairfield 65
Jacksonville 56
Wilmington 56
Singapore 47
Seattle 38
Dublin 37
Houston 32
Medford 30
Nanjing 27
Beijing 22
Des Moines 22
Altamura 20
Princeton 18
Dearborn 17
Palermo 17
Abidjan 16
Cambridge 16
Brussels 13
Tulsa 13
Boardman 11
Lawrence 11
Ludwigshafen am Rhein 11
Hebei 9
Jinan 9
Ningbo 9
Shenyang 9
Cagliari 8
Kumar 8
Nanchang 8
New York 8
San Diego 8
Bremen 7
Seongnam 7
Berlin 6
Changsha 6
Milan 6
Tianjin 6
Central 5
Jiaxing 5
Venice 5
Verona 5
Fuzhou 4
Helsinki 4
San Mateo 4
Santa Clara 4
Auburn Hills 3
Hangzhou 3
Taiyuan 3
Taizhou 3
Zhengzhou 3
Andover 2
Aragona 2
Chiclayo 2
Corato 2
Dallas 2
Guangzhou 2
Haikou 2
Lanzhou 2
Munich 2
Napoli 2
Rubano 2
Sacramento 2
San Giovanni La Punta 2
San Paolo di Civitate 2
Tehran 2
Almaty 1
Columbus 1
Coventry 1
Den Haag 1
Draveil 1
Düsseldorf 1
Edinburgh 1
Florida 1
Frankfurt am Main 1
Gallipoli 1
Hefei 1
Izmir 1
Kiev 1
Kilburn 1
Kitzingen 1
Kota Kinabalu 1
London 1
Los Angeles 1
Mazara Del Vallo 1
Ottawa 1
Phoenix 1
Pune 1
Quartucciu 1
Saint Petersburg 1
San Jose 1
Sandston 1
Shanghai 1
Springfield 1
Stepnogorsk 1
Walnut 1
Wandsworth 1
Totale 1.274
Nome #
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 165
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 165
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 162
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 160
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 150
Splenic marginal zone lymphoma: a prognostic model for clinical use. 132
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 130
Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial. 111
Radiochemioterapia neoadiuvante nel carcinoma del retto localmente avanzato 103
Carcinoma ereditario dell'ovaio (Ereditary Ovarian Cancer) 96
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients 96
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 95
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule 94
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients 84
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 84
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 75
R-RESCOVITINE ( SELICICLIB ) INHIBITS DNA DAMAGE-INDUCED CYCLIN A! UP-REGOLATION AND HINDERS NON-HOMOLOGOUS END JOINING: A RATIONAL FOR THERAPEUTIC COMBINATIONS WITH DNA DAMAGING AGENTS 65
R-Rescovitine (Seliciclib) inhibits DNA damage-induced Cyclin A1 up-regulation and hinders non-homologous end joining: a rationale for therapeutic combinations with DNA damaging agents. 60
Totale 2.027
Categoria #
all - tutte 6.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020253 0 0 0 0 33 40 37 16 27 28 55 17
2020/2021214 8 21 2 20 21 0 18 10 36 13 31 34
2021/2022230 17 47 1 22 9 6 8 6 23 39 14 38
2022/2023344 51 60 8 50 40 48 15 17 42 3 10 0
2023/2024151 6 19 9 8 12 25 12 40 1 1 0 18
2024/2025108 10 17 31 34 16 0 0 0 0 0 0 0
Totale 2.027